KM Research Hub
← 返回结果库查看论文详情PubMed ↗
READ-ONLY DIGITIZATION RESULT

Exploratory Analysis of Biomarkers and Treatment Outcomes from the COLUMBUS Study in BRAF V600E/K-Mutant Advanced or Metastatic Melanoma.

Clin Cancer Res · 2026-Apr-01 · PMID 41537702

Panel D提取完成待 EXE 对齐验证

OS

Figure 1. PFS and OS for encorafenib plus binimetinib or encorafenib vs. vemurafenib by ( A and B ) TMB and ( C and D ) cytolytic score. E, Volcano plots of univariable gene expression associations with OS in each arm based on z -scored gene expression values. F, Gene-set enrichment analysis of gene expression associations against hallmark gene signatures; signatures with greatest average NES across arms shown. Bini, binimetinib; BM, biomarker; CYT, cytotoxic score; Enco, encorafenib; NES, normalized enrichment scores; Vemu, vemurafenib.

算法:legacy-0.5.0引擎:enhanced-linux
质量评分0.73
质量通过是
预期曲线6
实际曲线6
X 范围-
Y 范围-

曲线数据

网页最多预览 200 行,完整数据请下载 CSV 或 JSON。

当前面板没有可预览的 `curves_mapped.csv` 数据。
历史版本(1)

重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。

版本状态验证曲线时间
legacy-0.5.0complete待验证62026-07-23T16:56:28+00:00